{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:29:17Z","timestamp":1787840957776,"version":"build-2784847793"},"reference-count":15,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T00:00:00Z","timestamp":1242086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Comparative Oncology"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Histiocytic sarcoma (HS) is associated with a poor prognosis owing to the presence of metastasis at the time of diagnosis in most dogs. Improved outcome has been reported in several dogs with localized HS following local therapy, however, distant metastasis occurs in 70\u201391% of dogs suggesting that adjuvant systemic therapy is necessary. The purpose of this retrospective study was to describe clinical characteristics and outcome in dogs with localized HS treated with aggressive local therapy plus adjuvant CCNU chemotherapy. Data from 16 dogs were evaluated. The median disease\u2010free interval was 243 days. Two dogs had local recurrence and eight dogs developed metastatic disease with a median time to relapse of 201 days in these 10 dogs. The median survival time for all 16 dogs was 568 days. These results support the recommendation for aggressive local therapy combined with adjuvant CCNU chemotherapy in dogs with localized HS.<\/jats:p>","DOI":"10.1111\/j.1476-5829.2009.00186.x","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T02:09:58Z","timestamp":1242180598000},"page":"139-144","source":"Crossref","is-referenced-by-count":64,"title":["Long\u2010term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy<sup>*<\/sup>"],"prefix":"10.1111","volume":"7","author":[{"given":"K. A.","family":"Skorupski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. O.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L.","family":"Krick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1354\/vp.39-1-74"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1354\/vp.43-5-632"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1354\/vp.39-1-66"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5810.2006.00090.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.2007.00292.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2460\/javma.1986.188.09.1041","article-title":"Malignant histiocytosis in Bernese Mountain dogs","volume":"188","author":"Rosin A","year":"1986","journal-title":"Journal of American Veterinary Medical Association"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/030098589303000306"},{"key":"e_1_2_5_9_2","first-page":"409","article-title":"Malignant histiocytosis of the dog: 26 cases (1989\u20131992)","volume":"38","author":"Kohn B","year":"1993","journal-title":"Kleintierpraxis"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.tb02937.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5810.2004.0053b.x"},{"key":"e_1_2_5_12_2","first-page":"3643","article-title":"The genetic origin of drug resistance in neoplasms: implications for systemic therapy","volume":"44","author":"Goldie JH","year":"1984","journal-title":"Cancer Research"},{"key":"e_1_2_5_13_2","first-page":"349","volume-title":"The Basic Science of Oncology","author":"Boyer MJ","year":"2005"},{"key":"e_1_2_5_14_2","first-page":"2112","volume-title":"Principles and Practice of Radiation Oncology","author":"Prosnitz LR","year":"2004"},{"key":"e_1_2_5_15_2","first-page":"2157","volume-title":"Principles and Practice of Radiation Oncology","author":"Wasserman TH","year":"2004"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-072160558-6.50015-0"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5829.2009.00186.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5829.2009.00186.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:08:04Z","timestamp":1739099284000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5829.2009.00186.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,12]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1476-5829.2009.00186.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5829.2009.00186.x","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,12]]}}}